Month: February 2026

Protected: CTF provides the next generation of dementia researcher’s an opportunity for early lab experience.

There is no excerpt because this is a protected post.

Have you heard of Roche’s Brainshuttle technology and why it’s the first of its kind in Alzheimer’s disease treatments?

You may have heard of trontinemab, an experimental Alzheimer’s disease treatment nicknamed “the jab” for its administration via IV – but have

Top